Tag: Pharmaceutical Industry
Politics |
FDA Considers Changes to Expert Review Process for New Drug Applications
FDA potentially shifting away from external expert reviews for new drug applications raises concerns about transparency and accountability.
Business |
Trump Administration's Novel Approach to Drug Pricing Strategy
President Trump's new tactic to lower drug prices involves a unique international pricing strategy. Learn more about this bold move.
Politics |
New Presidential Order Requires Transparency in Pharmaceutical Advertising
President Donald Trump has issued an order demanding increased transparency in pharmaceutical advertising on television and social media platforms.
Opinion |
Robert F. Kennedy Jr.'s Advocacy for Children's Health and Vaccine Safety
Explore Robert F. Kennedy Jr.'s commitment to improving children's health through vaccine safety advocacy and pharmaceutical accountability.
Business |
Eli Lilly Announces Global Regulatory Approval for New GLP-1 Weight Loss Pill
Eli Lilly plans to seek worldwide regulatory approval for a new weight loss pill harnessing GLP-1.
Opinion |
Implications of Robert F. Kennedy Jr.'s Anti-Vaccine Advocacy
Explore the concerns raised by pharmaceutical industry over Kennedy's stance on vaccines
Business |
Eli Lilly Announces Price Hike for Weight-Loss Medication
Eli Lilly raises prices for Mounjaro in the UK to impact US market
Business |
Pharmaceutical Industry Invests Billions in US Manufacturing Facilities Amid Tariff Concerns
Drugmakers in the pharmaceutical industry are ramping up investments in new manufacturing facilities in the US in response to potential tariffs on pharmaceutical imports.